Bioventus Investor Relations Material
Latest events
Q4 2023
Bioventus
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Bioventus Inc
Access all reports
Bioventus Inc. provides products focused on the orthopedic market, including Exogen Ultrasound Bone Healing System and DUROLANE family of single-injection joint fluid therapies. The company also offers biologics, such as concentrated bone marrow aspirate; allograft and xenograft products, OSTEOAMP bone regeneration allografts; and INTERFIX bone fixation devices. The company markets its products directly, as well as through distributors. Bioventus Inc. was founded in 2010 and is headquartered in Durham, North Carolina.
Key slides for Bioventus Inc
Q4 2023
Bioventus Inc
Q3 2023
Bioventus Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States